000			01600nam a2200373Ia 4500
001			ebr10662759
003			CaPaEBR
006			m u
007			cr cn|||||||||
008			090731s2010 nyua sb 001 0 eng d
010			_z 2009031817
020			_z9781612093680
020			_z9781607415657 (hardcover)
020			_z1607415658 (hardcover)
040			_aCaPaEBR _cCaPaEBR
035			_a(OCoLC)699510130
050	1	4	_aRJ560 _b.S24 2010eb
082	0	4	_a615/.190083 _222
245	0	0	_aSafety efforts in pediatric drug development _h[electronic resource] / _cConor D. Byrne, editor.
260			_aNew York : _bNova Science Publishers, _cc2010.
300			_axiv, 133 p. : _bill.
490	1		_aPharmacology--research, safety testing and regulation series
504			_aIncludes bibliographical references and index.
533			_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2013. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries.
610	1	0	_aUnited States. _tBest Pharmaceuticals for Children Act.
650		0	_aPediatric pharmacology _zUnited States.
650		0	_aPediatrics _zUnited States _xFormulae, receipts, prescriptions _xSafety measures.
650		0	_aDrug development _zUnited States _xSafety measures.
655		7	_aElectronic books. _2local
700	1		_aByrne, Conor D.
710	2		_aebrary, Inc.
830		0	_aPharmacology-research, safety testing, and regulation series.
856	4	0	_uhttp://site.ebrary.com/lib/rucke/Doc?id=10662759 _zAn electronic book accessible through the World Wide Web; click to view
999			_c70871 _d70871